Estriol may ease menopause-related cognitive decline - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Estriol may ease menopause-related cognitive decline

Women reported improvement across 6 cognitive domains during 12 months of estriol-based treatment, while murine models suggested a potential astrocyte-mediated mechanism.

  • By

  • Andrea Surnit

  • September 3, 2026

  • 3 min

Share

Clinical Scorecard: Estriol may ease menopause-related cognitive decline

At a Glance

CategoryDetail
ConditionMenopause-related cognitive decline
Key MechanismsEstriol treatment may improve cognitive function via estrogen receptor beta signaling in brain cells.
Target PopulationMenopausal women experiencing cognitive decline.
Care SettingStandard patient care in a clinical setting.

Key Highlights

  • 20 menopausal women with cognitive decline participated in the study.
  • Participants received oral estriol daily for 12 months.
  • Significant improvements were observed in cognitive symptoms across all assessed domains.
  • No randomization or placebo group was included in the study.
  • Cognitive changes were self-reported rather than measured through objective testing.

Guideline-Based Recommendations

Diagnosis

  • Cognitive symptoms assessed using the Voskuhl Menopause Brain Fog Assessment.

Management

  • Consider estriol-based hormone treatment for menopausal women with cognitive decline.

Monitoring & Follow-up

  • Monitor cognitive symptoms and overall health during treatment.

Risks

  • Caution advised due to lack of randomization and small sample size.

Patient & Prescribing Data

Menopausal women aged around 53.5 years.

Estriol doses varied (2 mg, 4 mg, 8 mg) and were individualized.

Clinical Best Practices

  • Evaluate cognitive symptoms in menopausal women.
  • Consider individualized hormone therapy based on clinical need.
  • Encourage further research into estriol's effects on cognition.

Related Resources & Content

Original Source(s)

Estriol may ease menopause-related cognitive decline

  • by Andrea Surnit

  • September 3, 2026

Related Content

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

Menopause Apps Offer Empowerment, but Pose Risks

Premenstrual Disorders Linked to Broad Psychiatric Risk

Swedish study finds two-way associations between premenstrual disorders and psychiatric conditions, with strongest links involving depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, and personality disorders.